MazF gene therapy / Takara, University of Pennsylvania - LARVOL DELTA

Redirected MazF‐CD4 Autologous T Cells for HIV Gene Therapy (clinicaltrials.gov) - P1; N=10; Active, not recruiting; Sponsor: University of Pennsylvania; Trial primary completion date: Mar 2017 ➔ Jul 2017

Trial primary completion date • Biosimilar • Gene Therapies • Human Immunodeficiency Virus • Immunology • Infectious Disease

Redirected MazF‐CD4 Autologous T Cells for HIV Gene Therapy (clinicaltrials.gov) - P1; N=10; Completed; Sponsor: University of Pennsylvania; Active, not recruiting ➔ Completed

Clinical • Trial completion